Stay updated on NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial
Sign up to get notified when there's something new on the NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial page.

Latest updates to the NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision entry v3.6.5 was added to the record history and the previous v3.6.4 entry was removed, indicating the study record has been updated.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe record history shows a new revision v3.6.4 replacing the previous v3.6.3. This reflects a minor maintenance update to the page rather than substantive changes to trial information.SummaryDifference0.1%

- Check48 days agoChange DetectedThe revision history now shows a new entry for v3.6.3, replacing the previous v3.6.2. This indicates a minor update to the page’s revision metadata.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision entry (v3.6.2) has been added to the study history, showing a software version update to the record-keeping interface.SummaryDifference0.1%

- Check70 days agoChange DetectedEnrollment is updated to no longer looking for participants, signaling that recruitment has ended. The revision history now shows a new tag v3.6.0, replacing the previous v3.5.5 tag.SummaryDifference0.4%

- Check77 days agoChange DetectedThe footer now shows Revision: v3.5.5 instead of Revision: v3.5.4, indicating a newer site version was deployed.SummaryDifference0.1%

Stay in the know with updates to NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial page.